Following yearlong advocacy efforts, the triple-combination therapy Trikafta is expected to soon come up for approval before Health Canada, the…
Articles by David Melamed, PhD
The Cystic Fibrosis Foundation (CFF) has awarded nearly $15 million to 33 organizations that are researching how to improve…
AzurRx BioPharma has launched a Phase 2b clinical trial investigating its MS1819 as a potential treatment for…
A potential way of killing persistent bacterial infections like those common to people with cystic fibrosis (CF) — using…
Investigational treatment Encala (Lym-X-Sorb) is safe, well tolerated, and increased dietary fat absorption in patients with cystic fibrosis (CF)…
Researchers identified a biochemical mechanism that regulates the thickness of mucus, and could serve as a target of new treatments…
Translate Bio‘s therapy MRT5005 has been given a rare pediatric disease designation by the U.S. Food…
The non-profit organization Claire’s Place Foundation has launched a donation-based COVID-19 Emergency Fund to support the cystic…
Prolonged use of the antibiotic azithromycin resulted in a 37% slower rate of lung function decline in cystic…
With the outbreak of coronavirus (COVID-19) affecting thousands of people around the world, individuals with respiratory conditions such as…